BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vandy FC, Stabler C, Eliassen AM, Hawley AE, Guire KE, Myers DD, Henke PK, Wakefield TW. Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord 2013;1:117-1125. [PMID: 23998134 DOI: 10.1016/j.jvsv.2012.09.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Mosevoll KA, Johansen S, Wendelbo Ø, Nepstad I, Bruserud Ø, Reikvam H. Cytokines, Adhesion Molecules, and Matrix Metalloproteases as Predisposing, Diagnostic, and Prognostic Factors in Venous Thrombosis. Front Med (Lausanne) 2018;5:147. [PMID: 29872658 DOI: 10.3389/fmed.2018.00147] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
2 Mosevoll KA, Lindås R, Tvedt TH, Bruserud Ø, Reikvam H. Altered plasma levels of cytokines, soluble adhesion molecules and matrix metalloproteases in venous thrombosis. Thromb Res 2015;136:30-9. [PMID: 25895848 DOI: 10.1016/j.thromres.2015.04.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
3 Schaefer JK, Jacobs B, Wakefield TW, Sood SL. New biomarkers and imaging approaches for the diagnosis of deep venous thrombosis. Curr Opin Hematol 2017;24:274-81. [PMID: 28306666 DOI: 10.1097/MOH.0000000000000339] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
4 Borgel D, Bianchini E, Lasne D, Pascreau T, Saller F. Inflammation in deep vein thrombosis: a therapeutic target? Hematology 2019;24:742-50. [DOI: 10.1080/16078454.2019.1687144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
5 Day DB, Xiang J, Mo J, Li F, Chung M, Gong J, Weschler CJ, Ohman-Strickland PA, Sundell J, Weng W, Zhang Y, Zhang JJ. Association of Ozone Exposure With Cardiorespiratory Pathophysiologic Mechanisms in Healthy Adults. JAMA Intern Med 2017;177:1344-53. [PMID: 28715576 DOI: 10.1001/jamainternmed.2017.2842] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 18.8] [Reference Citation Analysis]
6 Kuplay H, Erdoğan SB, Bastopcu M, Arslanhan G, Baykan DB, Orhan G. The neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio correlate with thrombus burden in deep venous thrombosis. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2020;8:360-4. [DOI: 10.1016/j.jvsv.2019.05.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
7 Wu J, Zhu H, Yang G, Wang Y, Wang Y, Zhao S, Zhao M, Peng S. IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosis. Oncotarget 2017;8:91391-401. [PMID: 29207652 DOI: 10.18632/oncotarget.20588] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Culmer DL, Dunbar ML, Hawley AE, Sood S, Sigler RE, Henke PK, Wakefield TW, Magnani JL, Myers DD Jr. E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model. Thromb Haemost 2017;117:1171-81. [PMID: 28300869 DOI: 10.1160/TH16-04-0323] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
9 Avila L, Amiri N, Pullenayegum E, Sealey VA, De R, Williams S, Vincelli J, Brandão LR. Diagnostic value of D-dimers for limb deep vein thrombosis in children: A prospective study. Am J Hematol 2021;96:954-60. [PMID: 33930198 DOI: 10.1002/ajh.26212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Coleman DM, Obi A, Henke PK. Update in venous thromboembolism pathophysiology, diagnosis, and treatment for surgical patients. Curr Probl Surg 2015;52:233-59. [PMID: 26071037 DOI: 10.1067/j.cpsurg.2015.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
11 Sanzo P, Niccoli S, Droll K, Puskas D, Cullinan C, Lees SJ. The effects of exercise and active assisted cycle ergometry in post-operative total knee arthroplasty patients - a randomized controlled trial. J Exp Orthop 2021;8:41. [PMID: 34159469 DOI: 10.1186/s40634-021-00363-w] [Reference Citation Analysis]
12 Galeano-Valle F, Ordieres-Ortega L, Oblitas CM, Del-Toro-Cervera J, Alvarez-Sala-Walther L, Demelo-Rodríguez P. Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review. Int J Mol Sci 2021;22:2627. [PMID: 33807848 DOI: 10.3390/ijms22052627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Frank B, Ariza L, Lamparter H, Grossmann V, Prochaska JH, Ullmann A, Kindler F, Weisser G, Walter U, Lackner KJ, Espinola-Klein C, Münzel T, Konstantinides SV, Wild PS; VTEval study group. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project. BMJ Open 2015;5:e008157. [PMID: 26133379 DOI: 10.1136/bmjopen-2015-008157] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
14 Anghel L, Sascău R, Radu R, Stătescu C. From Classical Laboratory Parameters to Novel Biomarkers for the Diagnosis of Venous Thrombosis. Int J Mol Sci 2020;21:E1920. [PMID: 32168924 DOI: 10.3390/ijms21061920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Audu CO, Gordon AE, Obi AT, Wakefield TW, Henke PK. Inflammatory biomarkers in deep venous thrombosis organization, resolution, and post-thrombotic syndrome. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2020;8:299-305. [DOI: 10.1016/j.jvsv.2019.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Metz AK, Diaz JA, Obi AT, Wakefield TW, Myers DD, Henke PK. Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology. Methodist Debakey Cardiovasc J 2018;14:173-81. [PMID: 30410646 DOI: 10.14797/mdcj-14-3-173] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Jacobs B, Vemuri C. The Future of Nanoparticle-Directed Venous Therapy. Semin Intervent Radiol 2017;34:73-80. [PMID: 28265133 DOI: 10.1055/s-0036-1597767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
18 Albricker ACL, Freire CMV, Santos SND, Alcantara MLD, Saleh MH, Cantisano AL, Teodoro JAR, Porto CLL, Amaral SID, Veloso OCG, Petisco ACGP, Barros FS, Barros MVLD, Souza AJD, Sobreira ML, Miranda RBD, Moraes DD, Verrastro CGY, Mançano AD, Lima RDSL, Muglia VF, Matushita CS, Lopes RW, Coutinho AMN, Pianta DB, Santos AASMDD, Naves BDL, Vieira MLC, Rochitte CE. Diretriz Conjunta sobre Tromboembolismo Venoso – 2022. Arquivos Brasileiros de Cardiologia 2022;118:797-857. [DOI: 10.36660/abc.20220213] [Reference Citation Analysis]
19 Jacobs B, Obi A, Wakefield T. Diagnostic biomarkers in venous thromboembolic disease. J Vasc Surg Venous Lymphat Disord 2016;4:508-17. [PMID: 27639008 DOI: 10.1016/j.jvsv.2016.02.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
20 Wang Y, Chen H, Zhang X, Gui L, Wu J, Feng Q, Peng S, Zhao M. Dimethyl 2,2'-[2,2'-(ethane-1,1-diyl)bis(1H-indole-3,2-diyl)]-diacetate: a small molecule capable of nano-scale assembly, inhibiting venous thrombosis and inducing no bleeding side effect. Int J Nanomedicine 2018;13:7835-44. [PMID: 30538462 DOI: 10.2147/IJN.S178683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Lattimer CR, Kalodiki E, Geroulakos G, Hoppensteadt D, Fareed J. Endogenous pro-thrombotic biomarkers from the arm and leg may not have the same value. Phlebology 2016;31:275-82. [DOI: 10.1177/0268355515589678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Blann AD. Soluble P-selectin: the next step. Thromb Res 2014;133:3-4. [PMID: 24216322 DOI: 10.1016/j.thromres.2013.10.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
23 Diaz JA, Fuchs TA, Jackson TO, Kremer Hovinga JA, Lämmle B, Henke PK, Myers DD Jr, Wagner DD, Wakefield TW; for the Michigan Research Venous Group*. Plasma DNA is Elevated in Patients with Deep Vein Thrombosis. J Vasc Surg Venous Lymphat Disord 2013;1. [PMID: 24187669 DOI: 10.1016/j.jvsv.2012.12.002] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
24 Ponomaryov T, Payne H, Fabritz L, Wagner DD, Brill A. Mast Cells Granular Contents Are Crucial for Deep Vein Thrombosis in Mice. Circ Res 2017;121:941-50. [PMID: 28739590 DOI: 10.1161/CIRCRESAHA.117.311185] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 7.6] [Reference Citation Analysis]